Jacobson Allan Steven Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
11
Insider Sells Sum
$5.91M

Insider Activity of Jacobson Allan Steven

According to the SEC Form 4 filings, Jacobson Allan Steven, being in a position of

  1. director at PTC Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 26000 shares for $2.13M,
    over all time since 2014-03-18, has bought 0 shares, and sold 150129 shares for $8.91M.

Biography of Jacobson Allan Steven

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$2,132,0182100

Comparison of Insiders on Amount of Buys and Sells

2025-11-25SalePTC Therapeutics, Inc.
PTCT
director
14,199
0.0188%
$83.55$1.19M-14.36%
2025-11-24SalePTC Therapeutics, Inc.
PTCT
director
11,801
0.015%
$80.14$945,736-11.02%
2025-10-03SalePTC Therapeutics, Inc.
PTCT
director
12,000
0.016%
$65.00$780,000+9.74%
2025-08-28SalePTC Therapeutics, Inc.
PTCT
director
1,667
0.0021%
$50.15$83,600+44%
2025-03-04SalePTC Therapeutics, Inc.
PTCT
director
1,230
0.0015%
$51.52$63,370+10.31%
2024-01-22SalePTC Therapeutics, Inc.
PTCT
director
10,000
0.0133%
$27.38$273,804+24.79%
2023-05-11SalePTC Therapeutics, Inc.
PTCT
director
23,000
0.0314%
$55.08$1.27M-48.01%
2020-11-04SalePTC Therapeutics, Inc.
PTCT
director
20,000
0.0293%
$60.00$1.2M-27.03%
2020-10-16SalePTC Therapeutics, Inc.
PTCT
director
5,000
0.0074%
$51.29$256,450-8.93%
2020-04-20SalePTC Therapeutics, Inc.
PTCT
director
17,900
0.0273%
$51.04$913,558+1.69%
2020-04-17SalePTC Therapeutics, Inc.
PTCT
director
2,100
0.0032%
$50.16$105,332+5.16%
2015-06-18SalePTC Therapeutics, Inc.
PTCT
director
5,000
0.0151%
$50.13$250,650-44.32%
2015-03-18SalePTC Therapeutics, Inc.
PTCT
director
16,616
0.0534%
$76.00$1.26M-50.76%
2014-09-18SalePTC Therapeutics, Inc.
PTCT
director
2,000
0.0068%
$40.16$80,320+29.15%
2014-03-18SalePTC Therapeutics, Inc.
PTCT
director
7,616
0.0305%
$31.18$237,499+13.07%
Total: 15
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.